Stage III non-small cell lung cancer

Diagnosis

Staging

Treatment

Immunotherapy

2-deoxy-2-(18F)fluoro-D-glucose

anaplastic lymphoma kinase

B-raf proto-oncogene serine/threonine kinase

concurrent chemoradiotherapy

chronic obstructive pulmonary disease

endobronchial ultrasound

epidermal growth factor receptor

European Medicines Agency

electromagnetic navigation

oesophageal ultrasound

Food and Drug Administration

forced expiratory volume

formalin-fixed paraffin-embedded

fine needle aspiration

human epidermal growth factor receptor 2

human epidermal growth factor receptor 4

intensity-modulated radiotherapy

kirsten rat sarcoma viral oncogene homologue

multidisciplinary team

magnetic resonance imaging

next-generation sequencing

non-small cell lung cancer

programmed cell death protein-1

programmed cell death ligand-1

positron emission tomography

Progression-free survival

phosphatidylinositol 3-kinase catalytic subunit

c-ros oncogene 1 receptor tyrosine kinase

sequential chemoradiotherapy

maximum standardised uptake values

transbronchial needle aspiration

T – Primary Tumour, N – Regional Lymph Nodes, M- Distant Metastasis

tumour proportion score

thyroid transcription factor 1

transthoracic needle biopsy

video-assisted mediastinoscopy

video-assisted thoracoscopic surgery

volumetric modulated arc therapy